MARKET

VANI

VANI

Vivani Medical
NASDAQ
0.9380
-0.0820
-8.04%
After Hours: 0.9600 +0.022 +2.35% 17:25 03/30 EDT
OPEN
1.030
PREV CLOSE
1.020
HIGH
1.050
LOW
0.9227
VOLUME
441.96K
TURNOVER
--
52 WEEK HIGH
1.920
52 WEEK LOW
0.9054
MARKET CAP
79.40M
P/E (TTM)
-2.1993
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VANI last week (0323-0327)?
Weekly Report · 17h ago
Vivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating
TipRanks · 2d ago
Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.
Benzinga · 4d ago
Vivani Medical GAAP EPS of -$0.43 misses by $0.01
Seeking Alpha · 4d ago
*Vivani Medical 4Q Loss $6.6M >VANI
Dow Jones · 4d ago
Vivani Medical FY2025 net loss widens 13.2% to $26.6 million; loss per share holds at $0.43
Reuters · 4d ago
VIVANI MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 4d ago
Press Release: Vivani Medical Reports Fourth -3-
Dow Jones · 4d ago
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.